Clinical Labor

Tissue Donors and Research Subjects in the Global Bioeconomy

Clinical Labor

Experimental Futures

More about this series

Book Pages: 296 Illustrations: Published: February 2014

Subjects
Gender and Sexuality > Feminism and Women’s Studies, Science and Technology Studies > Feminist Science Studies, Sociology > Social Theory

Forms of embodied labor, such as surrogacy and participation in clinical trials, are central to biomedical innovation, but they are rarely considered as labor. Melinda Cooper and Catherine Waldby take on that project, analyzing what they call "clinical labor," and asking what such an analysis might indicate about the organization of the bioeconomy and the broader organization of labor and value today. At the same time, they reflect on the challenges that clinical labor might pose to some of the founding assumptions of classical, Marxist, and post-Fordist theories of labor.

Cooper and Waldby examine the rapidly expanding transnational labor markets surrounding assisted reproduction and experimental drug trials. As they discuss, the pharmaceutical industry demands ever greater numbers of trial subjects to meet its innovation imperatives. The assisted reproductive market grows as more and more households look to third-party providers for fertility services and sectors of the biomedical industry seek reproductive tissues rich in stem cells. Cooper and Waldby trace the historical conditions, political economy, and contemporary trajectory of clinical labor. Ultimately, they reveal clinical labor to be emblematic of labor in twenty-first-century neoliberal economies.

Praise

"Cooper and Waldby have done an admirable job of highlighting at least two key aspects of the bioeconomy that are in need of more theoretical and, especially, empirical work; these are the importance of contracts and assets." — Kean Birch, New Genetics and Society

“In the literature on contributors to medical knowledge, attention is most often focused on basic and applied researchers, funders, and regulators.  In Clinical Labor, Cooper and Waldby focus on an essential, overlooked, and perhaps exploited population, that of research subjects.  The authors are at their strongest in applying a Marxist theoretical perspective to class in medical research and the need to conceptualize participation in clinical trials as labor. . . . Recommended. Graduate students, researchers/faculty, and professionals/practitioners.” — M. D. Lagerwey, Choice

"It reveals the brute commercial nature of some of the bodily exchanges on which biomedical innovation increasingly relies." — Erik Malmqvist, Medicine, Health Care and Philosophy

"Poised to be not only a classic analysis of the bioeconomy, but the strongest exemplar of a style of analysis of which we urgently need more."  — Aaron Panofsky, Social Forces

"Melinda Cooper and Catherine Waldby's Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy offers a highly original, gendered analysis of expansive and emergent labor forms "hidden in plain sight" in the rapidly proliferating bioeconomy.... Clinical Labor provides a forceful instance of Marxist–feminist theory, focusing on the next stage of capital accumulation, worker consciousness, and potential opposition." — Rayna Rapp, Bulletin of the History of Medicine

"In scholarship on the contemporary role and practices of the biosciences in the production of knowledge, value, and life itself,Clinical Labor stands out as an important contribution that helps make sense of new incorporations of bodies, stratifications, and relation.... Clinical Labor is sweeping and comprehensive, fluidly showing how legal concepts and economic practices interweave with biomedical production and bioethics." — Janet K. Shim, American Journal of Sociology

"Overall, Clinical Labor is a compelling and thought-provoking book. It provides an excellent overview of political bioeconomy and brings up a broad range of intriguing questions for readers interested in biomedical economies or Marxist thought." — Heather Edelblute, ISIS

"Cooper and Waldby expertly offer a comprehensive and substantial argument for why a reconceptualization of human subject experimentation as clinical labor is necessary by outlining inadequacies and challenges within existing regulation. This book is a provocative read suitable for scholars in multiple fields of the social sciences." — Por Heong Hong, East Asian Science, Technology and Society

"Clinical Labor is a welcome contribution to social studies of biomedicine. The book should concern everyone interested in the articulation of life, value and labor in global (bio-)economies.... Critical studies of biomedicine would benefit from further engaging with Clinical Labor, both empirically and conceptually.” — Christian Haddad, Life Sciences, Society and Policy

"At last! A paradigm-shifting theorizing of 'biolabor'—largely invisible, underpaid, or donated work that produces invaluable human materials for highly lucrative pharmaceutical and assisted reproductive technology industries. Melinda Cooper and Catherine Waldby brilliantly analyze such labor as continuous with low-waged distributed piecework characteristic of twenty-first-century post-Fordist bioeconomies, including venture labor (high risk/no pay). These highly gendered and racialized divisions of labor are eerily bioethics-approved as they outsource risk to individual worker 'entrepreneurs' and put 'life itself' to work for biocapital. Brava!" — Adele E. Clarke, coeditor of Biomedicalization: Technoscience, Health, and Illness in the U.S.


Buy


Availability: In stock
Price: $26.95
Author/Editor Bios Back to Top

Melinda Cooper is a Senior Research Fellow in the Department of Sociology and Social Policy at the University of Sydney. She is the author of Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era.

Catherine Waldby is a Professorial Future Fellow in the Department of Sociology and Social Policy at the University of Sydney. She is coauthor, with Herbert Gottweis and Brian Salter, of The Global Politics of Human Embryonic Stem Cell Science: Regenerative Medicine in Transition and, with Robert Mitchell, of Tissue Economies: Blood, Organs, and Cell Lines in Late Capitalism, which is also published by Duke University Press.

Table of Contents Back to Top
Sales/Territorial Rights: World

Rights and licensing
Additional InformationBack to Top
Paper: 978-0-8223-5622-6 / Cloth: 978-0-8223-5608-0
Publicity material

Top